News Releases
-
March 9, 2020
AMP German Cannabis Group Receives Import Licence for Medical Cannabis for imports from European Union Countries
BERLIN, Germany, March 9, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “C...
-
March 7, 2020
AMP German Cannabis Group Closes First Tranche of Non-Brokered Private Placement
BERLIN, Germany, March 6th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX)...
-
January 15, 2020
AMP German Cannabis Group Provides Corporate Update
BERLIN, Germany, January 15th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: X...
-
January 8, 2020
AMP German Cannabis Group Announces Non-Brokered Placement Private Placement to Fund German Medical Cannabis Import Business
BERLIN, Germany, January 8, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “C...
-
November 18, 2019
AMP German Cannabis Group Receives an Import Licence for Medical Cannabis from the German State of Thuringia
Berlin and Erfurt, Germany – November 18, 2019 –– AMP German Cannabis Group Inc....
-
October 15, 2019
AMP German Cannabis Group Signs Distribution Agreement with CC Pharma, a Wholly Owned Subsidiary of Aphria and a Leading Pharmaceutical and Medical Cannabis Distributer in Germany
AMP to supply the growing Germany market with pharmaceutical medical cannabis imported fro...
-
October 10, 2019
AMP German Cannabis Group begins EU-GMP audit of its medical cannabis supply chain in Germany
BERLIN, Germany, October 10, 2019 –– AMP German Cannabis Group Inc. (“AMP”) (CSE: ...
-
October 8, 2019
AMP German Cannabis Group Enters into memorandum of understanding supply agreement for the import of EU-GMP medical cannabis into Germany
BERLIN, Germany, October 8, 2019 –– AMP German Cannabis Group Inc. (“AMP”) (CSE: X...
-
September 17, 2019
AMP German Cannabis Group Supplier, Pure Life Cannabis, Completes EU-GMP Gap Analysis
BERLIN, Germany, September 17, 2019 –– AMP German Cannabis Group Inc. (“AMP”) (CSE...
-
-
September 4, 2019
AMP German Cannabis Group Commence Trading on the CSE and Announces Investment Policy Focused on the European Medical Cannabis Industry
BERLIN, Germany, September 4, 2019 – AMP German Cannabis Group Inc. (“AMP” o...
-
August 22, 2019
Chinook Announces Name Change to AMP German Cannabis Group and Listing on the Canadian Securities Exchange
BERLIN, Germany, August 22, 2019 – Chinook Tyee Industry Limited (“Chinook” ...
-
June 15, 2019
Chinook Closes $1.5 Million Canadian Dollar Series A Private Placement
Chinook Insiders are the largest investors in the Series A financing as its German subsidi...
-
May 29, 2019
Chinook joins forces with a leading German pharmaceutical consulting company
Chinook establishes EU-GMP standards for its imports of medical cannabis to Germany fro...
-
May 8, 2019
Chinook Announces Stock Option Grant
BERLIN, Germany, May 8th, 2019 – Chinook Tyee Industry Limited (“Chinook”) (...
-
May 6, 2019
Chinook Announces Private Placement Financing
BERLIN, Germany, May 6th, 2019 – Chinook Tyee Industry Limited (“Chinook”) (...
-
May 3, 2019
Chinook Announces Dual Listing on the Frankfurt Stock Exchange
BERLIN, GERMANY, May 3rd, 2019 | Chinook Tyee Industry Limited (“Chinook”) (TS...
-
February 7, 2019
Chinook’s subsidiary, AMP Alternative Medical Products, enters into a memorandum of understanding with Pure Life Cannabis for export to Germany
ERFURT, Germany and EDMONTON, Feb. 7, 2019 /CNW/ – AMP Alternative Medical Prod...
-
February 5, 2019
Update on Chinook’s Investments in Germany
BERLIN, Feb. 5, 2019 /CNW/ – Chinook Tyee Industry Limited (“Chinook”)...
-
January 2, 2019
Chinook Announces New Directors and Officers
ERFURT, GERMANY, January 2nd, 2019 | Chinook Tyee Industry Limited (the “CompanyR...
-
December 3, 2018
Chinook subsidiary, AMP Alternative Medical Products, receives €500,000 Series B financing to fund its medical cannabis business in Germany
ERFURT, Germany, Dec. 3, 2018 /CNW/ – Chinook Tyee Industry Limited (“Chino...